A bipartisan bill promised greater transparency into where prescription drugs are manufactured. Then a key provision was ...

Doctors say the growing popularity of supplement stacking has exposed more Americans to botanicals like ashwagandha that can ...

The Trump administration is seeking industry input as it pushes to increase domestic production of critical generic drugs.

In a new paper in the New England Journal of Medicine, two medical experts argue that the FDA’s inspection-based system is failing to catch quality problems and propose five reforms aimed at ...

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns affecting your ...

Experts explain why some generics can fail, how quality problems cause harm, and what patients can do to demand better accountability. An investigation by MedShadow found that certain types of opioid ...

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects of your medications. In this installment, ...

Comments from the Commissioner signal that the agency is preparing to reduce clinical trial requirements. Independent experts say the change may increase the risk of ineffective or unsafe drugs ...

Millions of Americans take glucosamine for joint pain despite limited evidence that it works. Now, a new study suggests it could accelerate cognitive decline in some people with dementia ...

From 18th-century apothecaries to modern drive-thru drug stores, pharmacies have evolved in form, but their central purpose has stayed constant: They serve as community centers to help people navigate ...